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Abstract. During ovarian development stroma from the mesonephros penetrates and expands into the ovarian 
primordium and thus appears to be involved, at least physically, in the formation of ovigerous cords, follicles and surface 
epithelium. Cortical stromal development during gestation in bovine fetal ovaries (n ¼ 27) was characterised by 
immunohistochemistry and by mRNA analyses. Stroma was identified by immunostaining of stromal matrix collagen 
type I and proliferating cells were identified by Ki67 expression. The cortical and medullar volume expanded across 
gestation, with the rate of cortical expansion slowing over time. During gestation, the proportion of stroma in the cortex 
and total volume in the cortex significantly increased (P , 0.05). The proliferation index and numerical density of 
proliferating cells in the stroma significantly decreased (P , 0.05), whereas the numerical density of cells in the stroma did 
not change (P . 0.05). The expression levels of 12 genes out of 18 examined, including osteoglycin (OGN) and lumican 
(LUM), were significantly increased later in development (P , 0.05) and the expression of many genes was positively 
correlated with other genes and with gestational age. Thus, the rate of cortical stromal expansion peaked in early gestation 
due to cell proliferation, whilst late in development expression of extracellular matrix genes increased.
Additional keywords: extracellular matrix, proliferation, stroma.
Received 9 June 2018, accepted 18 August 2018, published online 3 December 2018
Introduction
Connective tissue or stroma plays an important role in the for-
mation of the ovary and during folliculogenesis as shown in
mouse (Weng et al. 2006), cow (Wandji et al. 1996) and human
(Heeren et al. 2015). Ovarian stroma contains fibroblasts and
extracellular matrix. The matrix contains reticular fibres (Ban-
deira et al. 2015), fibrillar collagens (Iwahashi et al. 2000;
Hummitzsch et al. 2013, 2015), decorin (Hummitzsch et al.
2013, 2015), fibronectin (Hummitzsch et al. 2013, 2015), ver-
sican (McArthur et al. 2000; Hummitzsch et al. 2013, 2015),
fribillins (Prodoehl et al. 2009; Hatzirodos et al. 2011; Hum-
mitzsch et al. 2013, 2015; Bastian et al. 2016), latent trans-
forming growth factor b (TGFb)-binding proteins (Prodoehl
et al. 2009; Hatzirodos et al. 2011; Bastian et al. 2016) and
hyaluronan (Kobayashi et al. 1999; Irving-Rodgers and Rodgers
2007). Stromal extracellular matrix components have been
linked to the growth and maturation of follicles in sheep (Huet
et al. 2001) by maintaining the shape of granulosa cells as well
as their survival and proliferation in vitro.
The ovarian stroma is initially derived from the underlying
mesonephros and infiltrates the genital ridge composed of the
somatic gonadal ridge epithelial-like (GREL) cells and primor-
dial germ cells–oogonia (Hummitzsch et al. 2013). When
stroma first penetrates the ovaries, it is vascularised with
capillaries. As it penetrates towards the surface of the ovary
primordium the stroma branches and thus corrals the germ cells
and somatic GREL cells into forming the ovigerous cords. This
region containing the ovigerous cords and the branches of
stroma becomes the cortex of the ovary, while the medullary
area is substantially mesonephric stroma containing the rete
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derived from mesonephric ducts. Later, commencing at the
medullary–cortical interface, primordial follicles are formed
and some become activated and develop further into primary
and preantral follicles (Sarraj and Drummond 2012; Smith et al.
2014). As the stroma reaches to below the ovarian surface, it
expands laterally below the surface sequestering a population of
GREL cells underlain by a basal lamina at the interface
(Hummitzsch et al. 2013); the hallmark of an epithelium. At
the final stage of ovarian development, the stroma just below the
surface develops into the avascular, collagen-rich tunica
albuginea.
Many changes in gene expression occur during fetal ovarian
development, such as expression of the pluripotency marker
POU class 5 homeobox 1 (POU5F1 or Oct4), deleted in
azoospermia-like (DAZL), forkhead box L2 (FOXL2), as well
as members of the TGF family including TGFB1, 2 and 3,
activins, inhibins and bone morphogenetic proteins (BMPs;
reviewed in Sarraj and Drummond 2012). The ovarian stroma
is potentially influenced by several factors, including members
of the TGFb pathway (Roy and Kole 1998; Bastian et al. 2016)
and androgens and oestrogens (Abbott et al. 2006; Loverro et al.
2010). Abnormal development of ovarian stroma could poten-
tially lead to an altered stromal volume in adulthood, as
observed in polycystic ovary syndrome (PCOS; Hughesdon
1982; Fulghesu et al. 2001; Abbott et al. 2006; Li and Huang
2008). Despite the importance of stroma, it is probably the least
studied compartment of the ovary. Using the bovine ovary,
which is similar to the human ovary (Adams and Pierson 1995;
Kagawa et al. 2009), including fetal ovarian development
(Hatzirodos et al. 2011), stereometric and gene expression
analyses were undertaken to evaluate stromal development
and the expression of several genes respectively, in relation to
major histological changes during the development of the ovary.
Materials and methods
Abattoir ovary collection
Bovine fetal ovarian pairs (n¼ 27) from different stages of
development were collected from pregnant Bos taurus cows
from a local abattoir (Thomas Foods International) and crown–
rump length (CRL)wasmeasured to estimate the gestational age
(Russe 1983). All samples were transported to the laboratory on
ice in Hank’s balanced-salt solution containing Mg2þ and Ca2þ
(HBSSþ/þ; Sigma-Aldrich Pty Ltd, Australia). To determine the
sex of fetuseswith CRL,10 cm in order to excludemales in this
study, a tail sample was taken, the DNA was extracted and a
polymerase chain reaction (PCR) for sex-determining region Y
(SRY) was performed as previously described (Hummitzsch
et al. 2013). For histology and immunohistochemistry, one
ovary from each pair was weighed and processed for further
analysis, whereas for RNA analysis, the corresponding ovary
was snap-frozen on dry ice and stored at 808C for subsequent
RNA extraction.
Ovaries of known gestational age
An additional group of fetal ovaries was derived from another
study inwhich the age of the fetus was known. The experimental
design of the cattle trial from which these fetal ovaries were
obtained has been described previously (Copping et al. 2014).
Briefly, the influence of diet on development in utero was
assessed on Santa Gertrudis (Bos taurusBos indicus) heifers
divided into four groups according to different dietary protocols
based on a two-by-two factorial crossover design. The heifers
were randomly assigned to either a high (H¼ 14% crude pro-
tein, (CP)) or low (L¼ 7% CP) protein diet 60 days before
conception to 23 days postconception (dpc; periconception
treatment). This diet was individually fed in stalls and straw (5%
crude protein) was available ad libitum. The ration was as iso-
caloric as possible in the ruminant and supplemented with a
commercial vitamin and mineral preparation (Ridley Agripro-
ducts). The heifers were synchronously artificially inseminated
to a single bull. At 23 dpc, half of each nutritional treatment
group was swapped to the alternative postconception treatment,
high or low. At the end of the first trimester (98 dpc), heifers
were culled and the fetuses and placentae were collected. The
fetuses were sexed and the fetal gonads were excised and
weighed. One gonad from each fetus was processed for histol-
ogy and two ovaries from each of the four groups were analysed
by morphometry.
Histology
Fetal ovaries from the abattoir (n¼ 27) and the ovaries of known
gestational age (n¼ 8) were fixed in 4% paraformaldehyde
(Merck Pty Ltd) in 0.1M phosphate buffer (pH 7.4) and
embedded in paraffin using a Leica EG 1140H (Leica Micro-
systems). Serial sections of 6mmwere prepared using aCM1850
V2.2 Leica microtome (Leica Microsystems), mounted on
Superfrost glass slides (HD Scientific Supplies) and stored at
room temperature until used for haematoxylin–eosin staining
and immunohistochemistry.
Sample grouping
Abattoir samples were sorted into five groups based on histo-
logical morphology, as follows: Stage I, ovigerous cord for-
mation (the period when the ovigerous cords are formed
(n¼ 7)); Stage II, ovigerous cord breakdown (the period when
most of the ovigerous cords have broken down (n¼ 4)); Stage
III, follicle formation (the period when most of primordial and
primary follicles have formed but the cords are still open to the
ovarian surface (n¼ 3)); Stage IV, ovarian surface epithelium
formation (the time point when the ovarian surface epithelium is
completely formed (n¼ 8)) and Stage V, tunica albuginea for-
mation (the time point when tunica albuginea is formed (n¼ 5)).
Additionally, the age of each fetus was estimated from the CRL
(y¼0.0103x2þ 3.4332xþ 36.08, where y is age in days and x
is CRL in cm and calculated from the method of Russe (1983)).
Immunohistochemistry
An indirect immunofluorescence method was used for dual
localisation of Ki67 and collagen type I (Irving-Rodgers et al.
2002). Paraffin-embedded sections from different ovaries
(n¼ 35 animals) were dewaxed then subjected to a pressure-
cooker antigen retrieval method for 20min (2100 retriever;
Prestige Medical Ltd) in 10mM Tris–ethylenediamine tetra-
acetic acid (EDTA) buffer (pH 9.0). The primary antibodies
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used were mouse anti-human Ki67 (1 : 800; M7240/MIB-1;
DAKO Australia Pty Ltd) to identify proliferating cells in
combination with rabbit anti-human collagen type I (1 : 400;
20 mg mL1; ab34710; Abcam) to mark the stroma. Secondary
antibodies were donkey anti-mouse IgG conjugated to Cy3
(1 : 100; 715 166 151) and Biotin–(SP)-conjugated AffiniPure
donkey anti-rabbit IgG (1 : 100; 711 066 152) followed by
dichlorotriazinylamino fluorescein (DTAF)-conjugated strep-
tavidin (1 : 100; 016 010 084). All secondary antibodies and
conjugated streptavidin were from Jackson ImmunoResearch
Laboratories Inc. Cell nuclei were counterstained with 4’,6’-
diamidino-2-phenylindole dihydrochloride (DAPI) solution
(Molecular Probes). The bovine adult ovary was used as a
positive control whereas nonimmune mouse and rabbit sera
(Sigma-Aldrich) were used as negative controls. All sections
were photographed with an Olympus BX51 microscope with an
epifluorescence attachment and a Spot RT digital camera
(Diagnostic Instruments) at a magnification of 40.
Morphometric analyses
The largest cross-section from each ovary, determined by hae-
matoxylin–eosin staining for every 10th section, was examined
using NPD.view2 software (Hamamatsu Photon). Using the
ImageJ software (Schindelin et al. 2012), images of the cortex at
40 magnification were taken randomly with a single image
dimension set at 1600 1200 pixels (0.06mm2). Each image
represented a field of view that was used for morphometric
analysis in this study. The total number of fields of view to be
examined for each analysis was first determined by examining
the coefficient of variation (CV) of 3–40 fields of view. For
measuring the stromal area, the following steps were performed
(Fig. 1). First, the total cortical area was identified, saved as a
region of interest (tissue area) and its area measured. Next, the
stromal area in the cortex was identified based on positive col-
lagen type I staining (Fig. 2). To calculate the proportion of
stroma in the cortex (volume density) and total stromal volume,
the following calculationswere applied and all calculations used
equations that are listed in Table 1. The ovarian volume (Vovary)
was estimated using the ovarian weight, assuming a density of
1 g cm3. Then, the proportion of stroma in the cortex (Vv[stroma])
and the total stromal volume (Vstroma) were calculated using the
equations shown in Table 1. The number of proliferating stromal
cells (Ki67 positive) and all stromal cells (DAPI positive) in a
field of viewwere counted using themultipoint and findmaxima
tool with adjusted noise tolerance (ImageJ). Nuclei, which were
not detected by the threshold, were added manually using the
multipoint tool. Results of proliferating cells are presented as a
proliferation index (PI) and as a numerical density (Ndp/Nd) in
the stromal area using the equations shown in Table 1.
RNA extraction and cDNA synthesis
RNA was extracted from the whole fetal ovary using 1mL
Trizol (Thermo Fisher Scientific) with 0.5 g of ceramic beads
in homogenisation tubes using the Mo Bio Powerlyser 24 (Mo
Bio Laboratories Inc.) and 200mL chloroform (RNase-free)
according to the manufacturer’s instructions. The RNA con-
centration was determined using a Nanodrop spectrophotometer
(NanoDrop 1000 3.7.1; Nanodrop Technologies) based on the
260l (wavelength) absorbance. All samples which had a
260 : 280l absorbance ratio .1.8 were used and subsequently
treated with DNase I (Promega/Life Technologies Australia Pty
Ltd). ComplementaryDNAwas then synthesised from 200 ng of
DNase-treated RNA using 250 ng mL1 random hexamers
(Geneworks) and 200U Superscript Reverse Transcriptase III
(Thermo Fisher Scientific) as previously described (Matti et al.
2010). For a negative control, diethyl pyrocarbonate (DEPC)-
treated water instead of the Superscript Reverse Transcriptase
III was added.
Quantitative real-time PCR
To conduct quantitative real-time PCR (qPCR), primers were
designed against the published reference RNA sequences
(Table 2) using Primer3 plus (Rozen and Skaletsky 2000) and
Net primer (PREMIER Biosoft) software. To test the combi-
nation of primers, the cDNA was diluted to five different con-
centrations from 1 : 4 to 1 : 1000 to generate a standard curve of
cycle threshold (Ct) versus concentrations. Primer combinations
that showed a single sharp peak and achieved an amplification
efficiency of 0.9–1.1 and an R2 value $ 0.98 were used for
further analysis.
Quantitative PCR was carried out using a Rotor-Gene 6000
series 1.7 thermal cycler (Qiagen GmbH) in duplicate at 958C
ROI
stroma
ROI tissue
Tissue on
glass slide
Collagen
type I
Fields of view
(0.06 mm2)
Fig. 1. Schematic diagram of the procedure for determining the stromal
areas and proliferating cells in fetal ovarian tissues. For immunohistochem-
istry and subsequent analysis by ImageJ, the largest cross-section of each
fetal ovary was used and 20–40 fields of view (each 0.06mm2) were
randomly chosen from each section. Fluorescence staining for collagen type
I was used to distinguish between stromal and non-stromal areas and Ki67
was used to mark any proliferating cells in the ovarian tissue. In each
photograph the total ovarian tissue was marked as region of interest (ROI)
tissue and measured. The stromal area, marked by collagen type I fibres
(shaded areas), was identified as ROI stroma and measured. Ki67-positive
cells (black dots) and DAPI-positive cells (white dots) were counted in
stromal areas.
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for 15 s then 608C for 60 s for 40 cycles. Amplification of cDNA
dilutions were prepared in 10 mL reactions containing 2mL of
the 1 : 20 cDNA dilution, 5mL Power SYBRGreen PCRMaster
Mix (Applied Biosystems), 0.2 mL each of forward and reserve
primers (Geneworks; Table 2) for the target genes and 2.6mL of
DEPC-treated water. Ct values were determined using the
Rotor-Gene 6000 software (Q series; Qiagen GmbH) at a
threshold of 0.05 normalised fluorescence units. Gene expres-
sionwas determined by themean of 2DCt, whereDCt represents
the target gene Ct – glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) Ct. GAPDH was used as a housekeeping gene
because it is stably expressed in bovine adult ovarian tissues
(a) (b)
(c)
(e)
(d )
Fig. 2. Stromal distribution and proliferation in fetal ovaries from different developmental stages. Representative photographs from
(a) Stage I (ovigerous cord formation), (b) Stage II (ovigerous cord breakdown), (c) Stage III (follicle formation), (d) Stage IV (ovarian
surface epithelium formation) and (e) StageV (tunica albuginea formation) of fetal ovarian development showing stroma (S), ovigerous
cords–primordial follicles (markedwith asterisks), surface epithelium (SE), tunica albuginea (TA) and a preantral follicle (markedwith
diamond). The stroma was identified based on the expression of collagen type I, which is a stromal marker. Collagen type I (green) is
combined with the proliferation marker Ki67 (red, marked with arrows). Nuclei are counterstained with DAPI. Scale bar¼ 25 mm.
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Table 2. List of genes and primers used for quantitative real-time PCR
Gene name Gene symbol Primers (50-30) Genebank accession number Size (bp)
Glyceraldehyde-3-phosphate dehydrogenase GAPDH F: ACCACTTTGGCATCGTGGAG NM_001034034.2 76
R: GGGCCATCCACAGTCTTCTG
Osteoglycin OGN F: TGCAAGGCTAATGACACCAG NM_173946.2 85
R: GATGTTTTCCCAGGATGACG
Lumican LUM F: TTCAAAGCATTCGCCAAAATG NM_173934.1 62
R: CCGCCAATTAATGCCAAGAG
Asporin ASPN F: AAGGACATGGAAGACGAAGG NM_001034309.2 80
R: GGGAAGAAGGGGTTAATTGG
Fibromodulin FMOD F: AGGTGGGCAAGAAGGTTTTC NM_174058.2 129
R: TCTGGTTGTGGTCAAGATGG
Biglycan BGN F: CACCTTGGTGATGTTGTTGG NM_178318.4 202
R: TCTCGTCCGCTACTCCAAGT
Collagen type VI a1 chain COL6A1 F: CAAGGATGTCTTTGGCTTGG NM_001143865.1 120
R: AGAAGCTCGGCGTAGTTTTC
Collagen type VI a2 chain COL6A2 F: TCAAAGAGGCCGTCAAGAAC NM_001075126.1 84
R: TGAGCTTGTTGTAGGCGAAC
Collagen type VI a3 chain COL6A3 F: TCAATACCTACCCCAGCAAGA XM_005197965.3 200
R: GACCGCATCTAGGGACTTACC
Collagen type I a2 chain COL1A2 F: TTGAAGGAGTAACCACCAAGG NM_174520.2 321
R: TGTCCAAAGGTGCAATATCAA
Fibronectin FN1 F: CGACGGCATCACTTACAATG NM_001163778.1 118
R: CGACGGCATCACTTACAATG
Fibronectin extra domain A FN1-EDA F: CCTGTTACTGGTTACAGAGTG AF 260303 550
R: AGTGAGCTGAACATTGGG
Fibronectin extra domain B FN1-EDB F: GCCGATCAGAGTTCCTGCACC AF 260304 456
R: GAGCCCAGGTGACACGCATAG
Fibronectin V region FN1-V F: CTGAAGAACAATCAGAAGAG AF 260305 600
R: CCACTATGATGTTGTAGGTG
Lectin, galactoside-binding soluble 1 (galectin 1) LGALS1 F: AATCATGGCTTGTGGTCTGG NM_175782.1 129
R: AGGTTGTTGTCGTCTTTGCC
Regulator of G-protein signalling 5 RGS5 F: GCCATTGACCTTGTCATTCC NM_001034707.2 119
R: TTGTTCTGCAGGAGCTTGTC
Fibulin-1 FBLN1 F: GCAGCGCAGCCAAGTCAT NM_001098029.1 66
R: AGATATGTCTGGGTGCTACAAACG
Fibulin-2 FBLN2 F: TGGCACTCACGATTGTAACC XM_589271.8 130
R: GTTGATGTCCACGCATTTCC
Fibulin-5 FBLN5 F: TGCAACTGAGAATCCCTGTG NM_001014946 121
R: GCATTCGTCCATATCACTGC
Table 1. List of equations for morphometric analyses
Acortex, cortical area in each image; Aovary, ovarian area in each image; Astroma, stromal area in each image; Atotalstroma, total analysed stromal area;
Npstroma, total number of proliferating cells in all analysed images of the stroma;Nstroma, total number of cells in all analysed images of the stroma;Vovary,
ovarian volume
Parameter Equation Units
Proportion of cortex in the ovary or cortical volume density (Vv[cortical]) Vv[cortical]¼Acortex /Aovary %
Cortical volume (Vcortex) Vcortex¼Vv[cortical]Vovary mm3
Proportion of stroma in cortex or volume density of stroma in the ovarian cortex (Vv[stroma]) Vv[stroma]¼Astroma /Acortex %
Cortical stromal volume (Vstroma) Vstroma¼Vv[stroma]Vcortex mm3
Proliferation index in the cortical stroma (PI) PI¼Npstroma / Nstroma %
Numerical density of proliferating cells in the stroma (Ndp) Ndp ¼ Npstroma / Atotalstroma Nmm
2
Numerical density of all cells in the stroma (Nd) Nd¼Nstroma / Atotalstroma Nmm2
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(Berisha et al. 2002) and showed stable expression in our
samples.
Statistical analyses
All statistical analyses were carried out using Microsoft Office
Excel 2010 and GraphPad Prism Version 6.00 (GraphPad
Software Inc.). All data that were not normally distributed or
showed significantly different standard deviations between
groups were first log-transformed. The morphometric and 2DCt
data for each fetal ovarian sample were compared using
ANOVA with Tukey’s post-hoc test. A value of P, 0.05 was
considered to be significant. For testing the association between
expression levels of each gene throughout development, corre-
lation coefficients were determined using the Spearman corre-
lation coefficient. After correlation values between genes were
identified, a network graph was plotted using the qgraph R
package (Epskamp et al. 2012) and illustrated using an adjacent
matrix plot.
Results
Classification of ovaries
Aswe have observed previously (Hummitzsch et al. 2013), there
was variation in the developmental stage of ovaries from fetuses
of the same crown–rump length, particularly at early stages. We
therefore devised a classification system based upon five iden-
tifiable stages of development of the cortex commencing with
ovigerous cord formation (Stage I), ovigerous cord breakdown
(Stage II), follicle formation (Stage III), surface epithelium
formation (Stage IV) and tunica albuginea formation (Stage V)
as illustrated in Fig. 2 and subsequently analysed data from the
abattoir collection using this classification system.
Determination of total number of fields of view
Using the ovaries from our abattoir collections we first deter-
mined the optimum number of total fields of view required for
the morphometric measurements of the proportion of stroma in
the cortex and the proportion of proliferating stromal cells in the
ovarian cortex. A CV analysis was conducted from 3 up to 40
fields of view photographed at 40 magnification accounting
for 0.06mm2 (Fig. S1, available as Supplementary Material to
this paper). For fetuses with a CRL ,30 cm, the CV of the
volume density of stroma (Fig. S1a–c) and the proportion of
proliferating stromal cells in the ovarian cortex (Fig. S1g–i) was
relatively variable until nine fields of view and then remained
similar until 20 fields of view. However, for fetuses with CRL of
39 cm the CV of the proportion of stroma in the cortex (Fig. S1d)
and the proportion of proliferating stromal cells in the ovarian
cortex (Fig. S1j) were similar for almost all numbers of fields of
view. For fetuses with CRL.50 cm, the parameters were highly
variable from 3 to 20 fields of view (Fig. S1e, f, k, l) and then
stabilised from 20 to 40 fields of view. Thus, for morphometric
quantitation of fetuses with a CRL of ,50 cm we assessed
10 fields of view and for fetuses with a CRL of .50 cm we
assessed 20 fields of view.
Ovary changes in Stages I to V
Details of the ovaries and fetuses of each stage from our abattoir
collection are presented in Table 3. With advancing stages the
fetuses were older and the ovaries became significantly heavier
and they had more cortex and medulla, but proportionally less
cortex relative to medulla in the last two stages of development
(Table 3).We calculated the time to transit from one stage to the
next and fold changes between each stage in weight, cortical
volume and medullary volume (Table 3). The transition time
between Stages I and II, II and III, III and IV and IV and V were
48, 46, 61 and 30 days respectively (Table 3); thus, the duration
of development before Stage III was 94 (48þ 46) days and after
Stage III was 91 (61þ 30) days. From Stages I to III versus
Stages III to V the fold changes in weight were 6.2 and 4.2, the
fold changes in cortical volume were 6.7 and 2.0 and the fold
changes in medullary volume were 6.3 and 7.6 respectively
Table 3. Characteristics of developmental stages (I to V) of bovine fetal ovaries from the abattoir collection
Data are mean s.e.m. One-wayANOVAwith post hoc Tuckey’s tests were used to analyse data. a,b,c,dValues within a rowwith different superscripts indicate
significant differences (P, 0.05)
Parameter Developmental stage
I II III IV V
Gestational age (days)A,B 79 6a 127 6b 173 12c 234 9d 264 6d
Time from previous stage (days) 48 46 61 30
Weight (mg)B 17.9 5.1a 49.2 7.9b 113.5 33.6bc 245.8 62.9cd 475.3 22.6c
Fold change in weight from previous stage 2.7 2.3 2.2 1.9
Total cortical volume (mm3)B 10.3 3.0a 30.1 4.8b 70.7 27.4bc 65.5 9.0bcd 142.1 37.5cd
Fold change in cortical volume from previous stage 2.9 2.3 0.9 2.2
Cortical volume density (%) 56.9 3.0a 61.7 6.7a 59.7 9.1ab 33.2 5.5bc 29.5 7.0c
Total medullar volume (mm3)B,C 7.7 2.1a 19.0 4.5ab 42.8 9.5bc 180.3 57.9cd 333.1 34.8d
Fold change in medullar volume from previous stage 2.5 2.5 4.2 1.8
Total cortical stromal volume (mm3)B 3.3 0.8a 12.9 1.9b 43.4 20.1bc 49.6 7.3cd 112.7 28.1cd
Fold change in cortical stroma from previous stage 3.9 3.4 1.1 2.3
AEstimated from the CRL (Russe 1983).
BStatistical analysis was conducted using log-transformed data.
CCalculated from total cortical volume and percentage of medullar area.
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(calculated from Table 3). Thus, after Stage III when follicles
formed, the expansion of the cortex slowed but the medulla
continued to expand at its previous rate, leading to proportion-
ally more medulla. From 79 to 264 days of gestation the ovarian
volume increased 26.5 fold (17.9 to 475.3mm3), the cortex
increased 13.8 fold in volume (10.3 to 142.1mm3) and the
medulla increased 34.1 fold in volume (3.3 to 112.7 mm3).
Morphometric characteristics of fetal ovarian stroma
During ovigerous cord formation at Stage I (Fig. 2a), the stroma
containing many Ki67-positive cells formed branches between
ovigerous cords (Fig. 3c, d). At this stage the ovigerous cords
contained oogonia, undergoing mitosis as shown by colocali-
sation with the proliferation marker Ki67 (Fig. 2a). The pro-
portion of stroma in the ovarian cortex increased during
ovigerous cord breakdown at Stage II (Fig. 3a, b), although it
was not statistically significant. Ki67-positive cells were
observed in the stromal area and in the partitioned ovigerous
cords (Fig. 2b). In the stromal area, the total number of Ki67-
positive cells was lower than during Stage I (Fig. 3c, d); how-
ever, the difference was not statistically significant. During
follicle formation at Stage III (Fig. 2c), the proportion of stroma
in the ovarian cortex had increased further (Fig. 3a, b). The
stroma now surrounded the primordial follicles, whichwere first
formed at the inner cortex adjacent to the medulla. Proliferating
cells were observed in the stroma but not in primordial follicles
(Fig. 2c); however, the total number of Ki67-positive cells in
stroma were lower than during Stage II (Fig. 3c, d), although the
difference was not statistically significant. During the formation
of surface epithelium at Stage IV (Fig. 2d), the ovary had more
stroma underneath the ovarian surface. At this stage Ki67-pos-
itive cells localised in the stroma as well as the ovarian surface.
Tunica albuginea formation at Stage V was characterised by
bundles of thick collagen type I fibres underneath the ovarian
surface epithelium (Fig. 2e). At this stage stromal cells and some
granulosa cells in growing follicles were positive for Ki67.
We quantitatively measured the proportion of stroma in the
cortex and the total volume of the stroma in the cortex (Fig. 3)
and both were significantly increased during ovarian develop-
ment (P, 0.05; Fig. 3a, b). Interestingly, the cell proliferation
index of the stroma in the ovarian cortex significantly declined
during ovarian development (Fig. 3c). The numerical density of
proliferating cells also significantly declined in the cortical
stroma throughout gestation (Fig. 3d). However, the numerical
density of cortical stromal cells was stable during ovarian
development (Fig. 3e), suggesting that the increase in stromal
volume during gestation was not affected by an increase in
extracellular space in the cortical stroma.
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To assess if our morphometric analyses used for the abattoir
collection were adequate, we analysed fetal ovarian samples
from the trial collected on Day 98 of gestation. Using the CRL,
age was estimated by the method of Russe (1983) to be
95.3 1.2 days, which is in very good agreement with the
known age of 98 days. During this time of gestation, the stroma
occupied 26.1 0.1% of the cortex and was 3.9 0.2mm3 in
total volume. The proliferation index of the cortical stroma was
7.3 0.5%, the numerical density of the proliferating stromal
cells in the cortex was 1340 77 cells mm2 and the numerical
density of all the stromal cells was 18 737 607 cells mm2
(Table 4).
Gene expression
Weanalysed themRNAexpression of genes that are specifically
expressed in the stroma of many adult tissues, including the
ovary. The mRNA expression of osteoglycin (OGN), lumican
(LUM), asporin (ASPN), collagen type VI A1 (COL6A1),
COL6A2, COL6A3, fibronectin (FN1), regulator of G-protein
signalling 5 (RGS5) and fibulin 5 (FBLN5) in fetal ovaries sig-
nificantly increased in Stages IV and V of development
(Fig. 4a–c, g–j, o, r) relative to earlier stages. We also analysed
the mRNA expression of another threeFN1 splice variants (FN1
extra domain A (FN1-EDA), FN1 extra domain B (FN1-EDB)
and FN1 variable (FN1-V)), which have three different addi-
tional domains. Our results showed that FN1-EDA, FN1-EDB
andFN1-Vwere also significantly increased late in development
(Fig. 4k–m). The expression of fibromodulin (FMOD), biglycan
(BGN), COL1A2, FBLN1, FBLN2 and Lectin galactoside-
binding soluble 1 (galectin 1) (LGALS1) did not show any sig-
nificant differences across stages of ovarian development
(Fig. 4d–f, n, p, q).
Correlation analyses
To analyse the correlations between the 18 genes of interest and
additionally with gestational age (Table 5), we generated the
Spearman correlation matrix from the Ct values of all genes.
After correlation values between genes were identified, a net-
work graph was plotted using the qgraph R package (Epskamp
et al. 2012) to plot an adjacent matrix (Fig. 5) and some
examples of these are correlations as shown in Fig. 6. OGN,
LUM,ASPN,BGN,COL6A1,COL6A2,COLA3,COL1A2,FN1,
FN1-EDA, FN1-EDB, FN1-V, RGS5, FBLN1 and FBLN5 were
all strongly positively associated with each other (r .0.6). In
addition, FMOD had strong positive correlations (r. 0.6) with
BGN, COL6A1, COL6A2, COLA3, COL1A2, FN1, FN1-EDA,
FN1-EDB, FN1-V and LGALS1. FBLN2 and LGALS1 showed
weaker positive relationships to other genes (r ,0.6). Gesta-
tional age had strong positive correlations (r.0.6) withFBLN5,
LUM, RGS5, ASPN, OGN, FN1-EDB, COL6A3, COL6A2,
COLA1, FN1-V, FN1-EDA, COL1A2 and FBLN1, but had
weaker positive correlations (r,0.6) with FN1, BGN, LGALS1
andFMOD (Table 5). Interestingly,FBLN2 had aweak negative
correlation with gestational age (Table 5).
Discussion
In this study we conducted morphometric analyses of the
developing bovine fetal ovary, focusing on cortical stroma. We
were able to identify the stroma by immunostaining of the
stromal extracellular matrix collagen type I. We optimised our
morphometric sampling regime and also examined ovaries of a
known stage of gestation. Across gestation we measured the
total volume and relative proportions of cortex and medulla, the
proportion and total volume of stroma in the cortex and the
numerical and proliferation index of cells in the stroma of the
cortex. We also examined the expression of 18 genes that had
previously been reported as relevant to stroma in other organs.
We believe this is one of the first critical studies of the devel-
opment of ovarian stroma.
Collagen type I is an extracellular matrix of stroma that has
been localised in the stroma of fetal bovine (Hummitzsch et al.
2013) and rat ovaries (Paranko 1987), as well as adult bovine
(Figueiredo et al. 1995), mouse (Berkholtz et al. 2006) and
human (Lind et al. 2006) ovaries. Collagen type I was observed
at all stages of fetal bovine ovary development by immunostain-
ing but the intensity of immunostaining increased qualitatively
throughout development. This suggests that greater deposition
of collagen type I occurs during fetal development, leading to a
stiffer stromal matrix.
An earlier morphometric study examining the bovine fetal
ovary has been conducted but over a shorter period of time than
our study. From their results we calculated that the ovary volume
increased 4.2 fold in volume (35 to 148mm3), the cortex
increased 2.8 fold in volume (21.9 to 62.4mm3) and the medulla
increased 6.5 fold (13.1 to 85.6mm3) from 3 to 7 months of
gestation (Santos et al. 2013). Our measurements are in agree-
ment with theirs where, during Stages I to III (taking 94 days)
versus Stages III to V (taking 91 days) the changes in ovarian
weight were 6.2 and 4.2 fold, in medullary volume were 6.3 and
7.6 fold and in cortical volume were 6.7 and 2.0 fold respec-
tively. Our values are higher than theirs as our study was over a
longer time frame. Our results also show that throughout
gestation the medulla expanded substantially more (34.1 fold)
than the cortex (13.8 fold) did and that the rate of expansion of
the cortex declined past Stage III when follicles were formed.
What drives the continued expansion of the medulla is not
known, nor why this would continue.
The numerical density (cells per area or volume) of cells in
the cortical stroma, however, did not change across gestation.
Assuming that the sizes of the stromal cells did not change, and
there was no observable evidence that they did, then the
Table 4. Morphometric analyses of the cortical stroma in bovine fetal
ovaries from the trial at Day 98 of gestation
Data are mean s.e.m. (n¼ 8)
Characteristic Value
Weight (mg) 26.5 1.1
Total volume cortical stroma (mm3) 3.9 0.2
Proportion of stroma in the cortex (%) 26.1 0.1
Proliferation index of cortical stroma (%) 7.3 0.5
Numerical density of proliferating cells in cortical
stroma (Nmm2)
1340 77
Numerical density of cortical stromal cells (Nmm2) 18 737 607
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proportion of extracellular space in the cortical stroma was
constant across gestation. This is different from what is known
to happen in the tunica albuginea, which has a significantly
lower cell numerical density than cortical stroma and has
proportionally more extracellular space rich in extracellular
matrix containing at least collagens, versican, fibronectin,
decorin (Hummitzsch et al. 2013), latent transforming growth
factor b-binding protein 2 and fibrillin 1 (Prodoehl et al. 2009).
Thus, as also observed in the human fetal ovary from 20 to 25
weeks of gestational age (Sforza et al. 1993), there was an
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increase in stroma expansion across gestation but this rate of
expansion slowed after Stage III. These rates of expansion are
mirrored by the proliferation of stromal cells, but not the
proportion of extracellular space, suggesting that stromal cell
proliferation is largely responsible for stromal expansion during
ovarian development.
Since stroma has been shown to expand significantly during
ovarian development, genes that encode extracellular matrix
proteins that might be involved in the expansion of the ovarian
stroma were examined. Small leucine-rich proteoglycans
(SLRPs) have a role in regulating collagen type I fibrillogenesis,
which has been shown to be expressed during ovarian develop-
ment in the rat (Paranko 1987) and cow (Hummitzsch et al.
2013). There are three classes of SLRP, Class I, Class II and
Class III, which consist of extracellular matrix proteins, includ-
ing asporin (ASPN) and biglycan (BGN), lumican (LUM) and
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Fig. 5. Scatter plots showing related mRNA expression levels of (a) LUM
versus FBLN5, (b) FN1-EDB versus COL1A2 and (c) FN1-EDA versus
COL6A2 in whole bovine fetal ovaries. One ovary from each pair was used
for mRNA analysis (n¼ 27 pairs). Data are presented as normalised gene
expression toGAPDH. Spearman’s correlation coefficient (R) test was used
to analyse the data.
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fibromodulin (FMOD) and osteoglycin (OGN; Ameye and
Young 2002). ASPN and BGN have been shown to be involved
in collagen type I fibrillogenesis in human embryonic kidney
cells and adult mouse ovary respectively (Oksjoki et al. 1999;
Kalamajski et al. 2009). Another study showed that LUM and
FMOD bind to collagen type I in an antagonistic manner during
tendon development, which might be related to the formation of
progressively thicker collagen fibrils (Kalamajski and Oldberg
2009). Additionally, OGN is involved in regulating collagen
type I fibrillogenesis in mouse embryo fibroblasts (Ge et al.
2004). Since collagen type I also increases as the stroma expands
during ovarian development, our findings indicate that ASPN,
LUM and OGN might be involved in the deposition and assem-
bly of extracellular matrix in stroma in bovine fetal ovary.
The establishment and the remodelling of the ovarian vascu-
lar system is required for development of the ovary (Robinson
et al. 2009). Initially the penetration and expansion of the
mesonephric stroma into the developing ovary brings with it
capillaries contained therein (Hummitzsch et al. 2013; Smith
et al. 2014). It has been shown that RGS5 and FBLN5, which
encode regulator of G-protein signalling 5 and fibulin 5 protein
respectively, are involved in vascular remodelling (Berger et al.
2005; Spencer et al. 2005). RGS5 protein is a pericyte marker
observed in the vasculature of mouse ovarian follicles (Berger
et al. 2005), rat cerebral capillaries (Kirsch et al. 2001) and
mouse embryonic pericytes (Bondjers et al. 2003). Pericytes
have been observed in 23–24week human fetal ovary as a part of
a vascular network in the stroma (Niculescu et al. 2011).
Additionally, a study using FBLN5 knockout mice suggests
the important role of FBLN5 in neointima formation and
vascular remodelling after an induced vascular injury (Spencer
et al. 2005). Since the interaction between endothelial cells,
pericytes and smoothmuscle cells is critical for the development
of the vasculature (Niculescu et al. 2011), the increased
expression of RGS5 and FBLN5 suggests that these genes may
play a role in expansion of the vasculature in the cortical stroma.
COL6A1, COL6A2 and COL6A3 encode the extracellular
matrix component collagen typeVI,which is predicted to help in
anchoring tissues and cells to the connective tissue extracellular
matrix (Cescon et al. 2015). In human adult ovary, collagen type
VI is observed in the thecal layer, especially in the theca externa,
and has a role in the interactions between the thecal cell and
extracellular matrix during folliculogenesis (Iwahashi et al.
2000). A study using a yeast two-hybrid system showed an
interaction between collagen type VI and collagen type IV (Kuo
et al. 1997), which is localised in follicular basal lamina during
ovarian development (Hummitzsch et al. 2013). Additionally,
collagen type VI also interacts with other extracellular matrix
components, such as collagen type I (Bonaldo et al. 1990) and
fibronectin (Sabatelli et al. 2001). A study in the bovine fetal
ovary showed that collagen type I and fibronectin were specifi-
cally expressed in the ovarian stroma (Hummitzsch et al. 2013),
suggesting that collagen type VI might have an important role in
anchoring vasculature in the stroma during the late stage of
ovarian development.
FN1 encodes fibronectin, which modulates cell–cell and
cell–matrix interactions (Goldberg et al. 2006). Fibronectin is
composed of three structurally homologous types of repeated
domains: Type I, II and III. Three different alternative splicing
regions are located in Type III fibronectin: extra domain A
(ED-A), B (ED-B) and the variable (V) region, encoded byFN1-
EDA, FN1-EDB and FN1-V, respectively, (the variable region
can have three to five alternative splicing events). The ED-A,
ED-B and V regions are located between the 11th and 12th,
between the 7th and 8th and between the 14th and 15th Type III
repeats respectively (De Candia and Rodgers 1999). Collec-
tively, these alternative splicing events potentially produce
multiple different isoforms in humans, cows, mice and rats:
ED-Aþ, ED-A–, ED-Bþ, ED-B–, Vþ and V–. These have been
shown to be expressed in bovine antral follicles of 0.5–9mm
diameter, in corpora lutea and in fetal bovine liver, lung and
kidney but fetal ovaries were not examined in that study
(De Candia and Rodgers 1999). The ED-Aþ isoform has been
identified in ovarian follicles and is predicted to be associated
with the replication of granulosa cells (Colman-Lerner et al.
1999), whereas the ED-Bþ and Vþ isoforms have been shown
to be involved in angiogenesis (Castellani et al. 1994; DeCandia
and Rodgers 1999). It is possible that the isoforms of FN1 might
be involved in follicle formation and angiogenesis during
ovarian development.
Many of the genes examined in the present study were highly
positively correlated with gestational age and also with each
other. This is not surprising as many of these genes were
extracellular matrix genes associated with stroma, which also
expanded during fetal development. Comparisons with earlier
studies of bovine fetal ovaries (Hatzirodos et al. 2011) showed
that fibrillin 3, another extracellular matrix gene that is famil-
iarly linked to PCOS, is highly expressed only in the first
trimester and declines in expression thereafter. This is interest-
ing as fibrillin 3 is thus expressed in the fetal cortical stroma
when it is proportionally expanding the most during fetal
development. Why this particular gene should exhibit this
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FN1
RGS5COL6
A1
COL6
A2
COL6
A3
ASPN
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Fig. 6. An adjacent matrix network graph using correlation coefficients
from Table 5. The closeness of the genes and the thickness of the
interconnecting lines indicate stronger correlations between genes. Age is
age of gestation.
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behaviour and not other stromal extracellular matrix genes is not
known, but it does suggest that fibrillin 3may have a unique role
during ovarian cortical stroma expansion.
In summary we have shown quantitatively that the rate of
expansion of cortical stroma is greatest early in development
when the stroma penetrates the ovarian primordium from the
mesonephros. The expansion of the cortical stroma occurs due to
cell proliferation and not a change in cell size or a change in the
amount of extracellular space. The mRNA expression levels of
many extracellular matrix genes increased in the later stages of
ovarian development and were highly correlated with each
other, suggesting that theymight be co-regulated. In conclusion,
the behaviour of stroma changes during ovarian development
and this might have consequences for its roles.
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